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a  b  s  t  r  a  c  t
Rahnella aquatilis is an environmental Gram-negative bacillus that is rarely reported
as  human pathogen, being mainly associated with infections in immunocompromised
patients. Herein we describe two cases of R. aquatilis isolates recovered from endotracheal
aspirate cultures of different patients in a tertiary hospital located in the city of São Paulo,
Brazil. Matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry and 16S
rDNA  gene sequencing were performed to conﬁrm bacterial identiﬁcation after the isolates
being  erroneously identiﬁed as Pantoea spp. by automated system. Both isolates showed the
same PFGE pattern and presented the -lactamase encoding gene blaRAHN-1, responsible for
resistance to cephalothin. The isolates were susceptible to broad-spectrum cephalosporins,
carbapenems, ﬂuoroquinolones, aminoglycosides, and polymyxin B. This report shows thepresence and transmission of uncommon bacteria in the nosocomial environment and
alerts us about the need for new tools of correct microbiologic diagnosis.
© 2015 Elsevier Editora Ltda. All rights reserved.
2001, Bellais and colleagues reported a novel non-inducibleRahnella spp. is a facultative anaerobic and nitrogen ﬁxer
member of the Enterobacteriaceae family.1 This genus was
described in 1976, and was initially denominated as a Group
H of Enterobacteriaceae, based on numerical taxonomy. With
the advent of molecular techniques, this new genus was
renamed Rahnella. It has been mainly isolated from water
and soil, and therefore it can be abundantly found in
fresh products. The Rahnella genus comprises R. aquatilis, R.
∗ Corresponding author. Current address: Laboratório Especial de Microbio
Rua  Leandro Dupret, 188, Vila Clementino, 04025-010 São Paulo, SP, Bra
E-mail address: willamesbrasileiro@hotmail.com (W.  Martins).
http://dx.doi.org/10.1016/j.bjid.2015.07.009
1413-8670/© 2015 Elsevier Editora Ltda. All rights reserved.genomospecies 2 and R. genomospecies 3, that can be differ-
entiated only by molecular techniques.2 To date, few cases of
infection caused by R. aquatilis have been reported in liter-
ature, affecting mainly immunocompromised patients.1,3 Inlogia Clínica – LEMC, Universidade Federal de São Paulo – UNIFESP,
zil.
and chromosomally encoded Ambler class A -lactamase,
named RAHN-1, which is intrinsic of R. aquatilis strains.4 Two
variants of blaRAHN have been described to date (blaRAHN-1
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Fig. 1 – PFGE of R. aquatilis isolates. Lines 1 and 4 – Lambda
Ladder PFG Marker 50–1000 kb; Lines 2 and 3 – R. aquatilisb r a z j i n f e c t d i s .
nd blaRAHN-2), and contribute to one of the few resistance
echanisms described in this pathogen. Although clinical and
nvironmental RAHN-producing R. aquatilis strains reported
hus far were usually resistant to penicillins and narrow-
pectrum cephalosporins, these strains remained susceptible
o ceftazidime, imipenem, and were inhibited by clavulanic
cid.5
The identiﬁcation of R. aquatilis by classical microbiologic
eatures is difﬁcult, since there is not a single biochem-
cal test that could differentiate R. aquatilis isolates from
ther Enterobacteriaceae.6 R. aquatilis is a non-motile bacillus
t 35 ◦C (motile only at 25 ◦C), use citrate as the carbon source,
nd is able to ferment main carbohydrates, after 48 h incu-
ation at 35 ◦C. However, in MacConkey agar, a few weak
actose colonies are usually observed.2 R. aquatilis maybe
isidentiﬁed as Enterobacter agglomerans, since these bacte-
ia species share similar biochemical proﬁle. Thus, correct
dentiﬁcation by molecular techniques maybe required. In
he last years, matrix-assisted laser desorption/ionization
ime-of-ﬂight mass spectrometry (MALDI-TOF MS)  has been
stablished as a preferable alternative method for accurate
acterial identiﬁcation. Herein, we report the microbiological
eatures of RAHN-1-producing R. aquatilis isolates recovered
rom two patients admitted to a tertiary hospital in the city of
ão Paulo, Brazil.
Two different Gram-negative rods were recovered from
ndotracheal aspirate cultures of distinct hospitalized
atients, in the same period, at a neurological intensive care
nit (ICU). In the ﬁrst case, a 64 y-o male hospitalized for a
ong-term due to autoimmune encephalopathy associated
o Lyme disease was submitted to tracheostomy due to
espiratory disorders. During his stay, he developed various
nfections (respiratory and urinary) and received several
ourses of antimicrobial therapy. However, the patient had
ot been on antimicrobial therapy in the month before R.
quatilis isolation. After being hospitalized for ﬁve months,
he patient was diagnosed with a pulmonary infection due
o the presence of purulent endotracheal aspirate and radio-
ogical image  compatible with parenchymal lung inﬁltrate.
seudomonas aeruginosa and Pantoea spp. were identiﬁed
y Vitek®2 automated system (bioMérieux, Marcy  l’Etoile,
rance) in the endotracheal aspirate specimen, both at
105 UFC/mL. Meropenem therapy was introduced and clini-
al improvement was observed seven days thereafter. In the
econd case, a 37 y-o male with a degenerative neurological
yndrome (Hallervorden-Spatz syndrome) admitted to a long-
erm institution developed septic shock due to pulmonary
nfection in the left lower lobe, requiring mechanical ven-
ilation and vasoactive drug support. Antimicrobial therapy
ith teicoplanin and meropenem was initiated with clinical
mprovement after one week. No pathogen was recovered
rom any clinical samples collected after improvement. How-
ver, after two-month several bacterial isolates were cultured
rom blood samples in a period of one month, including a KPC-
roducing Klebsiella pneumoniae, following by KPC-producing
nterobacter aerogenes and Staphylococcus haemolyticus. The
atient was treated with multiple courses of antimicrobial
gents including tigecycline, amikacin, teicoplanin, and
eropenem. One week after ﬁnishing antimicrobial therapy
he patient presented with fever and a carbapenem-resistantisolates.
P. aeruginosa and Pantoea spp. isolates were recovered from
endotracheal aspirate. The patient received a new course of
tigecycline and amikacin therapy with clinical improvement.
Both Pantoea spp. isolates were referred to a reference
laboratory for conﬁrmation of bacterial identiﬁcation and
antimicrobial susceptibility. Mass spectrometry by Vitek® MS
(bioMérieux S/A, Marcy I’Etoile, France) identiﬁed both isolates
as R. aquatilis (score of 99%) and 16S rDNA gene sequencing
conﬁrmed those results with 100% similarity and coverage.
Rahnella species were recently included in the commercial
mass spectrometry databases, thus, allowing their identiﬁca-
tion from clinical and environment samples.7 To determine
the clonal relationship, pulsed-ﬁeld gel electrophoresis (PFGE)
using SpeI as the restriction enzyme was performed as pre-
viously described.8 The analysis was performed according to
the Tenover criteria.9 The Rahnella isolates belonged to a sin-
gle PFGE patterns (Fig. 1), suggesting that a patient-to-patient
transmission had occurred, since they were admitted to the
same ICU and shared the same hospital health care staff
in the same period of time. Caroff and colleagues described
one of the ﬁrst transmission of R. aquatilis in nosocomial
environment.10 In that study, because the patients were unre-
lated it was suspected that prolonged parental nutrition given
to by both patients was the source of spread. Other studies
identiﬁed the water used in the bronchial washing process and
citrate solution used in parenteral nutrition solution as the
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main sources of contamination by R. aquatilis.3,6,10 Fortunately,
no further transmission of R. aquatilis has been observed and
investigation of the source was not evaluated.
Antimicrobial susceptibility was evaluated by determining
the minimal inhibitory concentrations (MICs) using broth
microdilution according to the CLSI guideline.11 The antimi-
crobial agents tested were ampicillin, amikacin, gentamicin,
cefepime, cephalothin, ceftriaxone, ceftazidime, aztreonam,
meropenem, imipenem, ciproﬂoxacin, levoﬂoxacin, and
polymyxin B. According to CLSI breakpoints,12 both iso-
lates were susceptible to levoﬂoxacin (MIC, ≤0.25 g/mL),
ciproﬂoxacin (MIC, ≤0.125 g/mL), gentamicin (MIC,
≤0.125 g/mL), amikacin (MIC, ≤0.5 g/mL), ampicillin
(MIC, 8 g/mL), cefepime (MIC, 0.25 g/mL), ceftriaxone
(MIC, 1 g/mL), aztreonam (MIC, 1 g/mL), imipenem (MIC,
0.25 g/mL), meropenem (MIC, ≤0.06 g/mL), and polymyxin
B (MIC, 4 g/mL). Since the isolates were resistant only to
cephalothin (MIC, 128 g/mL), the presence of -lactamases
encoding genes was investigated by PCR followed by DNA
sequencing using the ABI3500 Genetic Analyzers (Applied
Biosystems, Foster City, CA). The presence of blaRAHN-1
gene was detected in both isolates, justifying resistance
to cephalothin observed in these isolates. Although the
two R. aquatilis isolates were susceptible to broad-spectrum
cephalosporins, previous studies have demonstrated that
RAHN-1 shows hydrolytic activity against cefotaxime and
ceftriaxone.4 So far, all isolates of Rahnella spp. reported in
the literature, were susceptible to most antimicrobials agents
tested. Thus, broad-spectrum cephalosporins are usually
employed for the treatment of infections caused by these
pathogens. In contrast, in some cases when R. aquatilis is
isolated with another pathogen, the antimicrobial treatment
must take into account the coverage against both pathogens.
Human infections caused by R. aquatilis are infrequent and
had not been previously reported in Brazil, which could be jus-
tiﬁed, at least in part, by the inability of automated systems
to identify environmental microorganisms. Since R. aquatilis
biochemical proﬁle is very similar to that of other Enterobac-
teriaceae, like Pantoea spp. and Enterobacter spp., more reliable
techniques are crucial to identify environmental isolates from
clinical specimens in order to better deﬁne the epidemiolog-
ical role played by these species in the nosocomial environ-
ment. In this context, MALDI-TOF MS  seems to be a reliable
tool in the identiﬁcation of such isolates. Due to the isolation
of multi-drug resistant P. aeruginosa strains in the same clinical
specimens where R. aquatilis were also isolated, it is difﬁcult to
deﬁne the exact role of R. aquatilis as the pathogen responsible
for ventilator-associated pneumonia. However, the isolation
of environmental multisusceptible bacteria in the hospital
setting could represent a real threat, since, generally, this
microorganisms carried virulent determinants and are able
to easily acquire resistant genes carried by motile genetic ele-
ments from other common pathogens. Thus, the emergence
of such microorganisms as clinically signiﬁcant pathogens,
especially in immunocompromised patients, is worrisome.
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